AstraZeneca has announced that it is to shed over 7,000 jobs worldwide; this is in addition to over 20,000 jobs that it has already cut since 2007. And the UK-based company is not expecting a reversal in fortunes any time soon. According to an official statement the outlook is gloomy: ...
Helen Sloan, Globe Business Publishing Ltd | 03 Feb 2012
There will be an awful lot written about the Facebook IPO over the coming weeks and months by people a lot more qualified than me to be making comments. However, it would be wrong not to point out one very obvious aspect of the planned float: the extent to which the success of the ...
Joff Wild, IAM Magazine | 02 Feb 2012
The latest issue of IAM is now available to subscribers online. Our cover story, written Australian patent attorney Mark Summerfield, who is also the author of the Patentology blog, takes a detailed look at the smartphone patent wars. With cases being fought around the world and different ...
Joff Wild, IAM Magazine | 02 Feb 2012
![[premium]](/images/homepageredesign/premium.png)
The IAM IP personalities of 2011 may not all be human beings, but each and every one made a significant impact on,
or contribution to, the IP world last year, and will continue to
do so for the foreseeable future
The Supreme Court recently ruled that rights holders should bear the cost of storing and destroying infringing goods where Customs cannot collect from the importer. The court saw no justification to use public funds to cover the cost of protecting private property, overruling the district court's decision to that effect.
According to the State Administration for Industry and Commerce, in the first half of 2011 the number of trademark applications increased by 34.84% compared to the same period in 2010. As a result, this year China is expected to achieve a record high for the number of trademark applications filed.
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European structured products), NYSE Euronext's equities markets (the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca) represent one-third of the world's equities trading - the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com.